$STRW

Strawberry Fields REIT Q2 Earnings Call Highlights

Strawberry Fields REIT (STRW) reported Q2 adjusted funds from operations (AFFO) of $73.9 million and projected 10.1% AFFO-per-share growth. It posted adjusted EBITDA of $135.7 million, 14.4% lease yield, and net debt to net assets of 49.8%. The board approved a $0.17 quarterly dividend. The company closed a $300 million credit facility and contracted to buy a Missouri hospital campus for $10.4 million.

Original reporting
Published Aug 9, 2026, 9:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 9, 2026, 9:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Strawberry Fields REIT Q2 Earnings Call Highlights — source image
Decision brief

The 30-second read

$STRWBullishMed
01

Why it matters

Traders can update expectations for AFFO growth, dividend income, and leverage trajectory based on disclosed guidance, payout ratio, and financing structure, while monitoring deal-closing timing into year-end.

02

Market read

New, decision-relevant disclosures include AFFO guidance, dividend declaration, a $300M credit facility, and a contracted acquisition plus a quantified transaction pipeline.

03

What to watch

Debt refinancing and September maturities could increase execution risk; also, the acquisition is small ($10.4M), so incremental AFFO impact may be limited versus portfolio scale.

Relevance 7/10Novelty 6/10Timing: post-call, ahead of Q3 dividend payable Sept. 30 and third-quarter acquisition close

Background

The article summarizes Strawberry Fields REIT’s Q2 earnings call, including AFFO/EBITDA metrics, dividend approval, new credit facility terms, and an announced Missouri campus acquisition.

Company-level read

Ticker impact

$STRWBullishMedium confidence
Context

Strawberry Fields reported Q2 AFFO of $73.9M, guided 10.1% AFFO-per-share growth, and approved a $0.17 Q3 dividend.

Expected impact

Moderately positive bias, with follow-through risk tied to deal-closing timing and leverage/debt refinancing execution.

Evidence & confidence

The article discloses multiple decision-relevant datapoints: AFFO and AFFO-per-share growth outlook, dividend declaration, and a credit facility plus acquisition pipeline that can affect future AFFO and leverage.

Market effects

Adds evidence of continued healthcare real estate deal flow and master-lease expansion strategy, relevant to skilled nursing REIT sentiment.

Kansas City, Missouri hospital campus acquisition could modestly influence local healthcare real estate demand expectations.

Limited, as the financing references SOFR and Israel shekel-denominated debt but the disclosed actions are company-specific.

Counterpoint

The pipeline implies uneven timing, so near-term AFFO delivery may lag the headline growth target if closings slip into later quarters.

Key entities

  • Strawberry Fields REIT

    Self-administered REIT focused on skilled nursing and healthcare real estate; reported Q2 AFFO and guided AFFO-per-share growth.

  • Moishe Gubin

    CEO quoted on financing plans and acquisition strategy.

  • Missouri Hospital Campus acquisition

    Contracted $10.4M purchase near Kansas City, Missouri, to be added to an existing master lease.

Related articles

$STRWMed

Strawberry Fields REIT (STRW) Q2 2026 Earnings Call Transcript

Strawberry Fields REIT (STRW) held its Q2 2026 earnings call. For the first six months of 2026, revenue rose to $80 million (+6.4%) and net income was $18.4 million. AFFO was $73.9 million, with projected 10.1% AFFO growth per share in 2026. The company reported 100% rent collection, $300 million credit facility, and a $0.17 Q3 dividend.

Med

Green Thumb Industries: Is This Profitable Cannabis Stock Still Undervalued?

Green Thumb Industries (GTBIF) reported Q2 revenue of $306.7M, EBITDA of $84.3M, and net income of $4.9M. The company grew revenue by 4.6% YoY and maintains a strong balance sheet with $283.6M in cash and $283M in debt. It repurchased 7.9M shares in Q2. Despite challenges, its financial flexibility and potential federal reform make it a notable player in the cannabis industry.

$MDTMedAI 8/10

Can Medtronic’s (MDT) Core Units Keep Up With Management’s New Bets?

Medtronic (MDT) reported strong Q1 results, raising its fiscal 2027 revenue growth outlook to 7.25-7.75%. The company is investing in high-growth areas like robotic surgery and partnerships, such as a $700M deal for Cornerstone's Sentire Surgical System. However, it faces stiff competition from peers like Johnson & Johnson and Intuitive Surgical. Institutional investors, including BlackRock, are increasing their stakes in MDT.

$CTASHighAI 8/10

Cintas Reports Record $3.01 Billion In Q1 Revenue And Raises Fiscal 2027 Outlook

Cintas reported Q1 revenue of $3.01B, up 8.9% organically, with net income rising 12.3% to $551.7M. Gross margin improved to 51.5%. The company raised fiscal 2027 revenue guidance to $12.15B-$12.27B and adjusted diluted earnings to $5.45-$5.54 per share, excluding UniFirst acquisition effects. Cintas also returned $753.5M to shareholders via dividends and stock repurchases.

$PAYXHighAI 9/10

Paychex Reports $1.63 Billion In Q1 Revenue As Net Income Increases 12% To $429.7 Million

Paychex reported Q1 2027 revenue of $1.63B, up 6% YoY, with net income rising 12% to $429.7M. Growth was driven by payroll, human capital management, and PEO businesses. Operating income increased 14% to $619.2M, while operating margin improved to 38%. The company also reported higher interest income and reduced acquisition-related expenses. Paychex declared $423.6M in dividends and has a $1B share repurchase program.